Gelteq Ltd

GELS

Explore Our Financial Data > Companies > Gelteq Ltd
{{popupValue}}
{{popupSubtitle}}
Documentation
Excel
API
Download

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
GELS
CIK0001920092
SIC2834
SectorManufacturing
Industry CategoryPharmaceutical Products
Industry GroupPharmaceutical Preparations

Contact

AddressLEVEL 4, 100 ALBERT ROAD, SOUTH MELBOURNE VIC, C3, 3205
Website www.gelteq.com
Phone61390873990
CEONathan J. Givoni
EmployeesN/A

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$0.00
Pre-Tax Income$-3.57 million
Net Income$-3.57 million
Net Income to Common$-3.57 million
EPS$-0.29
View All
Balance Sheet
Cash$16,373.00
Assets$13.86 million
Liabilities$3.77 million
Common Equity$10.09 million
Liabilities & Equity$15.05 million
View All
Cash Flow Statement
Net Income$-3.57 million
Cash From Operating Activities$-714,753.49
Cash From Investing Activities$-98,933.11
Cash From Financing Activities$563,498.00
Change in Cash$-250,188.53
View All
Calculations
NOPAT$-2.22 million
EBITDA$-2.76 million
Price to EarningsN/A
Price to Book$0.27
ROE-31.66%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner

Major commercial expansion of its U.S. strategy through logistics and distribution agreementNEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, sports and other products, today announced a major expansion of its U.S. commercial strategy through an exclusive logistics and distrib

Article Link

Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand

Sportsgel signs first league-wide sports deal to be the official performance gel of the preeminent pickleball tour across the Oceania regionNEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces today that its sport-focused brand Sportsgel has been named an official sponsor of the Professional Pickleball Tour an

Article Link

Gelteq Launches SportsGel Brand and Signs Distribution Agreement with E-Commerce Solutions Company in Asia-Pacific Region, WPIC

SportsGel will feature a sports-specific range of products available for license, with first deal to launch in China in H1 2025NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announces the launch of its SportsGel brand. “SportsGel has been established to eliminate the common trade-off between performance versus tas

Article Link

Gelteq Appoints Matthew Jones as Head of Sports Performance

Leading internationally-experienced sports nutritionist joins the Company’s growing team to expand its sports verticalNEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Matthew Jones as Head of Sports Performance. He will oversee the growth, outreach, and customer strategy of Gelteq’

Article Link

Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Dr. Paul Wynne as its Chief Scientific Officer (“CSO”). Gelteq co-founder and CEO Nathan Givoni stated, “We believe Dr. Wynne’s distinguished record and expertise in formulation science and drug delivery systems will be instrumental

Article Link